An internationally recognized testing institution, assisting enterprises in achieving technological advancement.
ZHONGXI Testing has obtained inspection qualification certifications from multiple countries and regions worldwide. We possess a senior testing team and advanced testing methods, providing independent, impartial, and professional third-party verification services for global carbon projects.
Certified by multiple international standards such as CNAS, VCS, and GS, with reports universally applicable worldwide.
Covering 140+ countries and regions, it supports on-site detection and remote verification in multiple languages.
Adopt standard experimental methods to ensure accurate and reliable data.
Plant polysaccharides constitute a structurally diverse class of high-molecular-weight carbohydrates isolated from botanical sources including medicinal herbs, edible fungi, seaweeds, cereals, and fruits. Unlike storage polysaccharides such as starch, many plant-derived polysaccharides exhibit a remarkable spectrum of bioactive properties, including immunomodulation, antioxidant capacity, antitumor activity, hypoglycemic effects, hypolipidemic activity, gastrointestinal protection, and antiviral action. These activities are governed by intricate structure-activity relationships involving molecular weight distribution, monosaccharide composition, glycosidic linkage patterns, degree of branching, uronic acid content, sulfation degree, and conformational features such as triple-helix formation. Because bioactivity cannot be inferred from source or yield alone, rigorous activity testing is essential for substantiating health claims, supporting regulatory submissions, and guiding product development in the nutraceutical, pharmaceutical, and functional food industries.

Clients seek plant polysaccharide activity testing for several distinct yet interrelated purposes. Product development and formulation optimization require comparative activity data to select extraction methods, purification protocols, and raw material sources that maximize functional efficacy. Health claim substantiation for nutraceuticals and functional foods demands objective evidence of immunomodulatory, antioxidant, or metabolic activity to satisfy regulatory frameworks such as EFSA health claims regulation, FDA structure-function claims, and China's health food registration requirements. Pharmaceutical and preclinical development of polysaccharide-based drug candidates requires comprehensive activity profiling to identify mechanisms of action, establish dose-response relationships, and support investigational new drug (IND) applications. Quality control and batch consistency monitoring ensures that commercial polysaccharide products retain consistent bioactivity across production lots, safeguarding efficacy and consumer trust. Structure-activity relationship (SAR) research investigates how molecular features such as molecular weight, branching, and sulfation influence biological effects, guiding rational design of optimized polysaccharide derivatives. Finally, academic and contract research utilizes activity testing to elucidate mechanisms of action, validate traditional medicine claims, and discover novel bioactive carbohydrate structures.
We provide comprehensive plant polysaccharide activity testing services spanning chemical characterization, in vitro bioactivity assessment, cell-based functional assays, and in vivo efficacy evaluation. Our analytical portfolio includes, but is not limited to:
Chemical and structural characterization — including molecular weight distribution and polydispersity index (Mw, Mn, Mz) by high-performance size-exclusion chromatography coupled with multi-angle light scattering (HPSEC-MALS), monosaccharide composition analysis by high-performance anion-exchange chromatography with pulsed amperometric detection (HPAEC-PAD) or gas chromatography-mass spectrometry (GC-MS), glycosidic linkage analysis by methylation and GC-MS, uronic acid content determination, protein and polyphenol impurity quantification, sulfate content and sulfation degree, FT-IR and NMR structural fingerprinting, and triple-helix conformation assessment by Congo red assay.
Immunomodulatory activity — including macrophage activation assays (NO production, phagocytosis, cytokine secretion), dendritic cell maturation assays, natural killer (NK) cell Cytotoxicity assays, T and B lymphocyte proliferation assays, complement fixation assays, and Toll-like receptor (TLR) activation screening to identify pattern recognition receptor engagement.
Antioxidant activity — including DPPH, ABTS, and hydroxyl radical scavenging assays, ferric reducing antioxidant power (FRAP), oxygen radical absorbance capacity (ORAC), cellular antioxidant activity (CAA) assays, and superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) activity modulation in cell models.
Antitumor and antiproliferative activity — including MTT, CCK-8, and SRB Cytotoxicity assays against human cancer cell lines, apoptosis assessment by flow cytometry and caspase activation, cell cycle analysis, wound healing and transwell migration assays, and angiogenesis inhibition assays.
Metabolic and hypoglycemic activity — including alpha-glucosidase and alpha-amylase inhibition assays, glucose uptake assays in insulin-resistant cell models, adipocyte differentiation and lipolysis assays, cholesterol micellar solubility inhibition, and bile acid binding capacity.
Gastrointestinal and prebiotic activity — including simulated gastric and intestinal digestion resistance, fecal fermentation and short-chain fatty acid (SCFA) production profiling, probiotic growth promotion assays, and intestinal barrier integrity assays using Caco-2 monolayers.
Antiviral and antimicrobial activity — including plaque reduction assays, viral entry and replication inhibition assays, and minimum inhibitory concentration (MIC) determination against bacterial and fungal strains.
In vivo efficacy evaluation — including murine models of immunosuppression, tumor xenograft, diabetes, hyperlipidemia, and colitis, with endpoints including cytokine profiling, histopathology, and metabolic parameter assessment.
Our laboratories employ high-content imaging systems, flow cytometry, luminescence and fluorescence plate readers, real-time cell analysis (RTCA), LC-MS/MS for cytokine quantification, and confocal microscopy for mechanistic studies. These platforms enable quantitative dose-response characterization, with EC50 and IC50 values determined across broad concentration ranges, and mechanistic resolution extending to receptor-level and pathway-level interrogation.
Our testing protocols are anchored in ISO/IEC 17025-accredited quality management systems, ensuring metrological traceability, reproducibility, and international acceptance. We perform rigorous assay validation evaluating sensitivity, specificity, linearity, precision, accuracy, and robustness for each bioassay. For cell-based assays, we enforce strict Mycoplasma testing, cell line authentication, and passage number control to ensure data integrity. For in vivo studies, we adhere to AAALAC-accredited animal facility standards and ARRIVE guidelines for reporting.
Our chemical characterization workflows utilize certified reference standards for monosaccharide and linkage analysis, and we employ multiple orthogonal detection methods to confirm structural assignments. For molecular weight determination, we calibrate with narrow-dispersity pullulan or dextran standards and validate with MALS absolute molecular weight determination. For bioactivity assays, we include positive and negative controls in every run and express results as relative potency against reference standards where available, enabling cross-study comparability.
For research applications, we offer custom assay development, mechanism-of-action studies, structure-activity relationship (SAR) investigations, synergistic combination screening with conventional drugs, and longitudinal stability monitoring of polysaccharide bioactivity under various storage conditions. Our mass spectrometry-based approaches enable polysaccharide fingerprinting, impurity profiling, and metabolite identification following in vitro or in vivo exposure.
1. Integrated Chemical and Functional Characterization: We combine detailed structural analysis with comprehensive bioactivity profiling, enabling direct correlation of molecular features with biological effects and supporting rational product optimization.
2. Broad Spectrum of Bioactivity Assays: Our portfolio spans immunomodulatory, antioxidant, antitumor, metabolic, gastrointestinal, antiviral, and antimicrobial activities, providing a systems-level view of polysaccharide function from a single laboratory partner.
3. Ultra-Sensitive and Quantitative Readouts: Our platforms achieve detection limits in the picogram-per-milliliter range for cytokine quantification and enable EC50/IC50 determination with confidence intervals, supporting rigorous dose-response characterization.
4. Mechanistic Depth: Beyond phenomenological activity, we provide receptor-level and pathway-level interrogation, including TLR screening, NF-kappaB reporter assays, MAPK signaling analysis, and single-cell cytokine profiling, enabling identification of mechanism of action.
5. Complex Matrix Expertise: We have validated methods for challenging matrices including crude extracts, high-viscosity polysaccharide solutions, sulfated polysaccharides, and polysaccharide-protein conjugates, where conventional assays frequently fail due to interference or solubility limitations.
6. Expert Interpretive Support: Our team includes carbohydrate chemists, immunologists, pharmacologists, and regulatory specialists who provide not only analytical data but also contextual interpretation, SAR insights, and guidance on health claim substantiation and regulatory submissions.
7. Rapid Turnaround and Scalability: Standard turnaround is 5–10 business days for routine bioassays and 10–15 business days for comprehensive characterization packages, with expedited options available. Automated platforms ensure consistent high-volume capacity without compromising analytical quality.
8. Custom Research and Method Development: For clients with novel polysaccharide structures or specialized research objectives, we offer bespoke method development, validation, and technology transfer services, including high-throughput screening campaigns and preclinical efficacy evaluation.
Our plant polysaccharide activity testing services support a diverse range of clients, including nutraceutical and functional food manufacturers, pharmaceutical companies, botanical extract suppliers, traditional medicine practitioners, contract research organizations, academic investigators, and regulatory agencies. Whether for product development, health claim substantiation, quality control, mechanistic research, or preclinical evaluation, we deliver data that is analytically rigorous, biologically contextualized, and directly actionable for product optimization and scientific inquiry.
Plant polysaccharides represent a rich and underexploited source of bioactive compounds with significant potential in nutrition, therapeutics, and preventive medicine. Their clinical and commercial value depends not only on source and yield but on rigorously characterized bioactivity and well-defined structure-activity relationships. With our integrated chemical and functional characterization platforms, comprehensive bioassay portfolio, and deep carbohydrate domain knowledge, we empower clients to substantiate health claims, optimize formulations, and advance polysaccharide-based products from discovery to market. For plant polysaccharide activity testing that meets the highest standards of precision and biological relevance, our laboratory is your trusted partner.
Beijing ZKGX Institute of Science and Technology , combining applied research with technological transformation. It has evolved into a comprehensive research institute characterized primarily by a "task-driven disciplines" approach. Approved by relevant authorities, it currently operates as a third-party analytical testing technical service provider. Its affiliated laboratory facilities hold certifications including CMA and CNAS, possess an Experimental Animal Use License, and have achieved triple certification for ISO9001 Quality Management System, ISO14001 Environmental Management System, and ISO45001 Occupational Health and Safety Management System.